United States: Federal Circuit Issues Second GSK v. Teva Opinion On "Skinny" Label-Based Inducement - Perkins Coie LLP

The Federal Circuit's August 5, 2021 ruling in GlaxoSmithKline LLC v. Teva Pharm. USA, Inc. (link to issued opinion), is an important development in the law of "skinny"...